Transcription of Public Assessment Report Mutual Recognition …
{{id}} {{{paragraph}}}
MRPAR Picolax Powder for Oral Solution UK/H/1960/001/MR 1 Public Assessment Report Mutual Recognition Procedure PICOLAX POWDER FOR ORAL SOLUTION MRP no: UK/H/1960/001/MR UK licence no: PL 03194/0014 Applicant: Ferring Pharmaceuticals Limited MRPAR Picolax Powder for Oral Solution UK/H/1960/001/MR 2 PICOLAX POWDER FOR ORAL SOLUTION PL 03194/0014; UK/H/1960/001/MR LAY SUMMARY On 26th April 2010, Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Germany, Greece, Finland, France, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, the Netherlands, Norway, Portugal, Romania, the Slovak Republic, Spain and Sweden approved Ferring Pharmaceuticals Limited Marketing Authorisations (licences) for the medicinal product Picolax Powder for Oral Solution (UK/H/1960/001/MR).
MRPAR Picolax Powder for Oral Solution UK/H/1960/001/MR 1 Public Assessment Report Mutual Recognition Procedure PICOLAX POWDER FOR ORAL SOLUTION
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Citric Acid Anhydrous, Anhydrous Citric Acid, Brix Anhydrous Citric Acid, Brix, Industrial Production of Citric Acid, Citric acid, Citric Acid, Anhydrous, CITRIC ACID FERMENTATION OF, CITRIC ACID FERMENTATION OF ASPERGILLUS, FERROUS GLYCINATE PROCESSED WITH CITRIC, Anhydrous, Acid, ACID-BASE TITRATIONS